These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8876871)

  • 1. Acute renal failure with amphotericin B in lipid emulsion.
    Gales MA; Gales BJ; Alford KM
    Ann Pharmacother; 1996 Sep; 30(9):1036. PubMed ID: 8876871
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphotericin B in fat emulsion.
    Kintzel PE
    Am J Health Syst Pharm; 1996 Nov; 53(22):2701. PubMed ID: 8931810
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphotericin B infused in 20% lipid emulsion.
    Ryan KA
    J Intraven Nurs; 1996; 19(3):123-5. PubMed ID: 8788829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
    Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
    Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
    Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
    Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS.
    Manfredi R; Chiodo F
    Pharmacotherapy; 1998; 18(5):1087-92. PubMed ID: 9758320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B formulated in a lipid emulsion.
    Cleary JD
    Ann Pharmacother; 1996 Apr; 30(4):409-12. PubMed ID: 8729899
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.
    Schöffski P; Freund M; Wunder R; Petersen D; Köhne CH; Hecker H; Schubert U; Ganser A
    BMJ; 1998 Aug; 317(7155):379-84. PubMed ID: 9694753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal fat embolism following amphotericin B lipid complex injection.
    Tolentino LF; Tsai SF; Witt MD; French SW
    Exp Mol Pathol; 2004 Dec; 77(3):246-8. PubMed ID: 15507243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amphotericin B-intralipid 20% combination. In vivo evaluation of its tolerability].
    Débat Zoguéreh D; Poignard P; Sorriaux A; Brouqui P
    Ann Med Interne (Paris); 1997; 148(1):100-2. PubMed ID: 9137701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
    Pahissa A
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlates of acute renal failure in patients receiving parenteral amphotericin B.
    Bates DW; Su L; Yu DT; Chertow GM; Seger DL; Gomes DR; Platt R
    Kidney Int; 2001 Oct; 60(4):1452-9. PubMed ID: 11576359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
    Barcia JP
    Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B toxicity reduced by administration in fat emulsion.
    Anderson RP; Clark DA
    Ann Pharmacother; 1995 May; 29(5):496-500. PubMed ID: 7655134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid formulations of amphotericin B.
    Jones E; Goldman M
    Cleve Clin J Med; 1998 Sep; 65(8):423-7. PubMed ID: 9769563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
    Craddock C; Anson J; Chu P; Dodgson A; Duncan N; Gomez C; Mehta J; Sadullah S; Subudhi C; Yin JL
    Expert Opin Drug Saf; 2010 Jan; 9(1):139-47. PubMed ID: 19947901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B--not so terrible.
    Bishara J; Weinberger M; Lin AY; Pitlik S
    Ann Pharmacother; 2001 Mar; 35(3):308-10. PubMed ID: 11261528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid derivatives of amphotericin B in treatment of systemic candidiasis].
    Rosenthal E
    Presse Med; 2000 Mar; 29(8):428. PubMed ID: 10738509
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for nephrotoxicity associated with conventional amphotericin B therapy.
    Girmenia C; Cimino G; Micozzi A; Gentile G; Martino P
    Am J Med; 2002 Sep; 113(4):351. PubMed ID: 12361831
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphotericin B and cardiac toxicity--a case report.
    el-Dawlatly AA; Gomaa S; Takrouri MS; Seraj MA
    Middle East J Anaesthesiol; 1999 Feb; 15(1):107-12. PubMed ID: 10068976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.